Esperion to Participate in Upcoming 2024 Cantor Global Healthcare Conference

Rhea-AI Summary

Esperion (NASDAQ: ESPR) has announced its participation in the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024, at 10:55 a.m. ET. The event will be webcasted live and accessible through Esperion's investor and media website section. A replay will be available approximately two hours after the call and archived for about 90 days.

Esperion is a company focused on discovering, developing, and commercializing innovative medicines for patients with or at risk of cardiovascular and cardiometabolic diseases. Their mission is to help patients with high cholesterol reach their health goals by providing next steps in LDL-cholesterol reduction.

ANN ARBOR, Mich., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024, at 10:55 a.m. ET.

The live webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company’s website for approximately 90 days.

Esperion Therapeutics
At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases. The status quo is not meeting the health needs of millions of people with high cholesterol – that is why our team of passionate industry leaders is breaking through the barriers that prevent patients from reaching their goals. Providers are moving toward reducing LDL-cholesterol levels as low as possible, as soon as possible; we provide the next steps to help get patients there. Because when it comes to high cholesterol, getting to goal is not optional. It is our life’s work. For more information, visit esperion.com and esperionscience.com and follow us on X at twitter.com/EsperionInc.

Esperion Contact Information:
Investors:
Alina Venezia
investorrelations@esperion.com
(734) 887-3903

Media:
Tiffany Aldrich
corporateteam@esperion.com
(616) 443-8438

FAQ

When is Esperion (ESPR) participating in the 2024 Cantor Global Healthcare Conference?

Esperion (ESPR) is participating in the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024, at 10:55 a.m. ET.

How can I access Esperion's (ESPR) webcast for the 2024 Cantor Global Healthcare Conference?

The live webcast can be accessed on the investor and media section of Esperion's website. A replay will be available about two hours after the call and archived for approximately 90 days.

What is the main focus of Esperion's (ESPR) business?

Esperion focuses on discovering, developing, and commercializing innovative medicines to improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases, particularly those with high cholesterol.

What is Esperion's (ESPR) approach to treating high cholesterol?

Esperion's approach is to provide next steps in LDL-cholesterol reduction, supporting healthcare providers' efforts to reduce LDL-cholesterol levels as low as possible, as soon as possible for patients with high cholesterol.